UPPSALA, Sweden, Sept. 18, 2023 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces the submission of the New Drug Application (NDA) to the US Food and Drug Administration ...
Nov. 10, 2003 — Editor's Note: Discrepancies, confusion, and error surrounding intravenous (IV) epinephrine use increase the risk of over- or underdosing, according ...
The practice, in which users inject the blood of already intoxicated individuals, has fueled one of the fastest-growing H.I.V ...